IRIS
BERARDO, CLARISSA ANGELA IRIS
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.164
EU - Europa 655
AS - Asia 229
AF - Africa 3
Totale 2.051
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.152
IE - Irlanda 393
CN - Cina 224
FI - Finlandia 64
IT - Italia 59
DE - Germania 57
BE - Belgio 25
SE - Svezia 22
CZ - Repubblica Ceca 15
CA - Canada 12
UA - Ucraina 10
GB - Regno Unito 7
EG - Egitto 2
FR - Francia 2
IN - India 2
SG - Singapore 2
IR - Iran 1
MU - Mauritius 1
RO - Romania 1
Totale 2.051
Salva come PNG Salva come JPEG
Città #
Chandler 427
Dublin 391
Ashburn 65
Princeton 60
Lawrence 58
Helsinki 56
Medford 56
Beijing 52
Nanjing 40
Shanghai 38
Wilmington 35
Pavia 32
Ann Arbor 27
Jacksonville 27
Brussels 25
Hebei 17
Nanchang 17
Munich 14
Brno 12
Changsha 12
Toronto 12
New York 10
Shenyang 10
Hangzhou 8
Jiaxing 8
Des Moines 7
Fairfield 7
Los Angeles 6
Seattle 6
Tianjin 6
Houston 5
Raleigh 5
Redwood City 5
Berlin 4
Brescia 4
Cagliari 4
Dearborn 4
Falls Church 4
Laurel 4
Washington 4
Alexandria 3
Brdo 3
Chicago 3
Guangzhou 3
Andover 2
Bovisio Masciago 2
Cambridge 2
Caronno Pertusella 2
Fuzhou 2
Menlo Park 2
Ningbo 2
Orange 2
Paderno Dugnano 2
Rockville 2
Rome 2
Singapore 2
Boardman 1
Clearwater 1
Falkenstein 1
Frankfurt am Main 1
Giussano 1
Gunzenhausen 1
Leawood 1
Littleton 1
Melegnano 1
Milan 1
Pune 1
San Francisco 1
Southend 1
Timisoara 1
Urbandale 1
Venegono Superiore 1
Verona 1
Verrua Po 1
Woodbridge 1
Totale 1.639
Salva come PNG Salva come JPEG
Nome #
Changes in ADMA/DDAH pathway after hepatic ischemia/reperfusion injury in rats: the role of bile. 100
Increase in transporter MATE-1 expression induced by obeticholic acid correlates with higher biliary excretion of asymmetric dimethylarginine during hepatic ischemia/reperfusion injury 55
Fatty liver oxidative events monitored by autofluorescence optical diagnosis: Comparison between subnormothermic machine perfusion and conventional cold storage preservation 53
Autofluorescence discrimination of metabolic fingerprint in nutritional and genetic fatty liver models 52
Changes in biliary levels of arginine and its methylated derivatives after hepatic ischaemia/reperfusion 51
Liver graft susceptibility during static cold storage and dynamic machine perfusion: DCD versus fatty livers 51
Comparison between Lipofectamine RNAiMAX and GenMute transfection agents in two cellular models of human hepatoma 51
Animal Models of Steatosis (NAFLD) and Steatohepatitis (NASH) Exhibit Hepatic Lobe-Specific Gelatinases Activity and Oxidative Stress 50
Associations between serum trace elements and inflammation in two animal models of nonalcoholic fatty liver disease 50
Fluorescing fatty acids in rat fatty liver models 48
The farnesoid X receptor agonist obeticholic acid upregulates biliary excretion of asymmetric dimethylarginine via MATE-1 during hepatic ischemia/reperfusion injury 47
Long-term cold storage preservation does not affect fatty livers from rats fed with a methionine and choline deficient diet 47
Nonalcoholic fatty liver disease and non-alcoholic steatohepatitis: Current issues and future perspectives in preclinical and clinical research 46
Liver plays a central role in asymmetric dimethylarginine-mediated organ injury 44
Oxygen tension-independent protection against hypoxic cell killing in rat liver by low sodium 44
Selective blockade of the metabotropic glutamate receptor mGluR5 protects mouse livers in in vitro and ex vivo models of ischemia reperfusion injury 44
Detailed Molecular Mechanisms Involved in Drug-Induced Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis: An Update 41
Fatty acid desaturase involvement in non-alcoholic fatty liver disease rat models: Oxidative stress versus metalloproteinases 40
Localization and role of metabotropic glutamate receptors subtype 5 in the gastrointestinal tract 39
Isolation of rat hepatocytes for pharmacological studies on metabotropic glutamate receptor (mGluR) subtype 5: a comparison between collagenase I versus collagenase IV. 38
Serum and hepatic autofluorescence as a real-time diagnostic tool for early cholestasis assessment 37
Obeticholic acid reduces biliary and hepatic matrix metalloproteinases activity in rat hepatic ischemia/reperfusion injury 37
SAT-389-Obeticholic acid reduces matrix metalloproteinases activity via iNOS modulation in hepatic ischemia/reperfusion injury 36
The FXR agonist obeticholic acid decreases matrix metalloproteinase activity via RECK and TIMP modulation in hepatic ischemia/reperfusion injury 36
MPEP, a metabotropic Glutamate Receptor 5 (mGluR5) negative allosteric modulator, protects from hepatic ischemic injury both in vitro and ex vivo. 34
Hepatic ischemia induces a time-dependent increase in SERPINB3 gene expression 34
Alterations in stearoyl-CoA-desaturase index and metalloproteinase activity in nutritional versus genetic rat models of NAFLD 34
P0006 : Hepatic ischemia/reperfusion induces changes in tissue and biliary levels of arginine and its methylated derivatives 33
Obeticholic Acid Reduces Kidney Matrix Metalloproteinase Activation Following Partial Hepatic Ischemia/Reperfusion Injury in Rats 32
Obeticholic acid restores hepatic RECK content in a diet-induced ob/ob mouse model of NASH 32
Fatty liver susceptibility to preservation injury using static cold storage versus dynamic machine perfusion 32
Cold ischemic injury is reduced by the mGluR5 negative allosteric modulator MPEP in rat livers from cardiac death donors 31
MicroCT evaluation of low-density segmented volume in II, IV and VII-week MCD rats 31
Analysis of Massaciuccoli Peat after Maturation in Sodium Chloride Water of Undulna Thermae 31
Allosteric modulation of mGlu5 receptors by MPEP protects against hepatic cold ischemia and reperfusion injury 31
The selective blockade of metabotropic glutamate receptor-5 attenuates fat accumulation in an in vitro model of benign steatosis 30
Negative allosteric modulators of metabotropic glutamate receptor subtype 5 protect against hepatic ischemia/reperfusion injury 30
INOS-mediated decrease of matrix metalloproteinase activity by obeticholic acid in hepatic ischemia/reperfusion 29
The Farnesoid-X-Receptor Agonist Obeticholic Acid Further Increases Biliary Excretion of Asymmetric Dimethylarginine during Hepatic Ischemia/Reperfusion Injury 29
RECK- and TIMP-mediated downregulation of matrix metalloproteinase activity by obeticholic acid in hepatic ischemia/reperfusion 28
Hepatic ischemia induces a time-dependent increase in SerpinB3 gene expression 28
Further increase in biliary excretion of asymmetric dimethylarginine during hepatic ischemia/reperfusion injury by obeticholic acid, a farnesoid-X-receptor agonist 28
OCA administration reduces lung matrix metalloproteinase activation following hepatic ischemia/reperfusion injury in rats 28
Upregulation of MATE-1 transporter by obeticholic acid correlates with increased biliary excretion of asymmetric dimethylarginine during hepatic ischemia/reperfusion injury 28
Hepatic ischemic injury decreases using negative allosteric modulators of metabotropic glutamate receptor subtype 5 28
NAD(P)H and Flavin Autofluorescence Correlation with ATP in Rat Livers with Different Metabolic Steady-State Conditions 27
Fluorescence excitation properties of bilirubin in solution and in serum 26
Selective Blockade of Metabotropic Glutamate Receptor by MPEP Protects against Hepatic Cold Ischemia and Reperfusion Injury 26
Benefits of Physical Exercise as Approach to Prevention and Reversion of Non-Alcoholic Fatty Liver Disease in Children and Adolescents with Obesity 25
Lobe-specific oxidative stress and matrix metalloproteinase activation in two animal models of non-alcoholic fatty liver disease (NAFLD) 25
Metabotropic glutamate receptor blockade reduces preservation damage in livers from donors after cardiac death 24
Oxidative stress, mitochondria damage and matrix metalloprotease activation in the pathogenesis of NAFLD 24
Machine perfusion at 20°C prevents ischemic injury and reduces hypoxia-inducible factor-1α expression during rat liver preservation 24
MCD diet-induced steatohepatitis is associated with alterations in asymmetric dimethylarginine (ADMA) and its transporters 23
Spectrofluorometric analysis of autofluorescing components of crude serum from a rat liver model of ischemia and reperfusion 22
Changes in glutathione content in liver diseases: An update 21
MPEP administration reduces steatosis and inflammation in ob/ob mice 20
Innovative targets involved in the progression of NASH: Asymmetric-dymethylarginine (ADMA) and its cationic transporters 18
Transient Expression of Reck Under Hepatic Ischemia/Reperfusion Conditions Is Associated with Mapk Signaling Pathways 17
The Effect of Healthy Lifestyle Strategies on the Management of Insulin Resistance in Children and Adolescents with Obesity: A Narrative Review 15
Metalloproteinases activation involvement in the progression of liver injury from NAFLD to NASH 15
MPEP Attenuates Intrahepatic Fat Accumulation in Obese Mice 13
Use of Physical Activity and Exercise to Reduce Inflammation in Children and Adolescents with Obesity 10
Totale 2.153
Salva come PNG Salva come JPEG
Categoria #
all - tutte 9.749
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.749
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20191 0 0 0 0 0 0 0 0 0 0 0 1
2019/2020212 59 70 12 3 0 3 3 2 0 24 34 2
2020/202179 2 2 1 2 0 15 17 17 11 6 5 1
2021/2022299 1 3 4 2 6 3 3 25 5 8 97 142
2022/20231.134 129 104 11 127 60 117 7 55 464 12 34 14
2023/2024325 66 43 15 18 34 69 41 23 0 15 1 0
Totale 2.153